NRGN and Alzheimer disease: The findings presented in the present study imply that CSF Ng might reflect the ongoing neurodegenerative processes within the CNS, indicating a role for Ng, and in particular Ng48–76, as a potential novel clinical biomarker for synaptic function in AD.